News | RIVM

No evidence of more serious illness from COVID-19 among Q fever patients

There are no indications that people who previously had Q fever had a more serious course of illness from the coronavirus SARS-CoV-2. This is evident from RIVM research.

Launch of Integrated Health Monitor COVID-19: large-scale study on public health impact of COVID-19

RIVM, the collective Municipal Public Health Services (GGDs) in collaboration with GGD GHOR, the NIVEL Netherlands Institute for Health Services Research and ARQ National Psychotrauma Centre have developed a new monitor: the Integrated Health Monitor

Vrouw achter bureau met laptop en staart uit het raam

Insight into hospital admissions for acute respiratory infections

In order to achieve an accurate overview of how often respiratory infections occur in the Netherlands, it is important to know how many patients are admitted to hospital with a respiratory infection.

Hospital admissions appear to have peaked, 44% fewer positive COVID-19 tests

541 new COVID-19 hospital admissions were reported last week, 23 fewer than in the week before, when 564 people with COVID-19 were admitted to hospital.

Long COVID also possible after a mild case: interim research results

More than 95% of the 1,741 participants in RIVM’s LongCOVID study, who reported long-term symptoms after COVID-19, had mild symptoms during the acute phase of the infection.

Antimicrobial resistance in the Netherlands stable in 2020

In 2020, the year of the coronavirus SARS-CoV-2 pandemic, resistant bacteria were not found more often in patients in the Netherlands than before the outbreak.

Number of positive COVID-19 tests doubled in one week

In the past week from 30 June to 6 July 2021, the number of reported positive COVID-19 tests doubled (+103%) compared to the previous week. This increase was observed in all security regions.

Delta variant on the rise

The delta variant of the coronavirus SARS-CoV-2 is occurring more and more often in the Netherlands.

Effects of COVID-19 vaccination becoming increasingly visible

In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.

Quality assessment of SARS-CoV-2 antigen test diagnostics: good performance at public test sites in the Netherlands

In their role as WHO reference laboratories, RIVM and Erasmus UMC conducted a study on the quality of SARS-CoV-2 antigen diagnostics in the Netherlands.